Physician

Karen K Swisher, MD

According to 2025 Medicare claims, Karen Swisher, MD (NPI: 1528176955) practices medical oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236. Swisher is affiliated with the Aledade A2916 KS MSSP Enhanced (ACO ID: A2916), Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546), Aledade 149 Regional MSSP (ACO ID: A5231), INTEGRIS Health Partners, LLC (ACO ID: A5331), Saint Francis Accountable Health Alliance LLC (ACO ID: A5372), Aledade 201 National MSSP (ACO ID: A5522), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Swisher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 721 traditional Medicare patients, billed 125,572 HCPCS/CPT codes, and received $1,948,973 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,300 prescription claims across 266 beneficiaries totaling $1,585,561 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 55 claims. Open Payments data shows 28 records totaling $2,517. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $174,502 to $1,948,973. Similarly, Part D prescription costs have risen steadily, from $61,704 to $1,585,561. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,552 and ending at $4,711.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $174,502 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $174,279 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $90,374 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $93,203 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $73,948 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $79,770 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $87,224 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $432,328 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,622,929 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,948,973 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155332,320$174,502
20166552,187$174,279
2017663781$90,374
2018673728$93,203
2019507543$73,948
2020506570$79,770
2021612668$87,224
202262135,643$432,328
2023457207,098$2,622,929
2024721125,572$1,948,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$827K$1.7M2015 Drug cost: $61,704 (USD; Tot_Drug_Cst)2016 Drug cost: $25,340 (USD; Tot_Drug_Cst)2017 Drug cost: $2,158 (USD; Tot_Drug_Cst)2018 Drug cost: $3,017 (USD; Tot_Drug_Cst)2019 Drug cost: $4,314 (USD; Tot_Drug_Cst)2020 Drug cost: $719 (USD; Tot_Drug_Cst)2022 Drug cost: $125,134 (USD; Tot_Drug_Cst)2023 Drug cost: $1,653,575 (USD; Tot_Drug_Cst)2024 Drug cost: $1,585,561 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151821,163$61,704
2016139396$25,340
20171561$2,158
20181445$3,017
2019N/R11$4,314
2020N/R12$719
2021N/RN/RN/R
202254115$125,134
20231651,313$1,653,575
20242661,300$1,585,561

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.2K$4.3K2015 Medicare payment: $1,622 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,757 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,882 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,111 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $4,341 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R34$1,622
2016N/R51$2,757
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R24$1,882
2023N/R24$2,111
2024N/R55$4,341

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more289595$87
96413Administration of chemotherapy into vein, 1 hour or less161247$86
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less107233$20
96372Injection of drug or substance under skin or into muscle110202$10
J1100Injection, dexamethasone sodium phosphate, 1 mg1041,725$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib19570$263,440
CalquenceAcalabrutinib Maleate13390$200,698
IbrancePalbociclib11308$172,290
EliquisApixaban391,168$22,863
AcyclovirAcyclovir983,565$1,340

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R22$2,914
E1392Portable oxygen concentrator, rentalYN/R22$883
E0601Continuous positive airway pressure (cpap) deviceYN/R11$544

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$2,517GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Karen K. Swisher, MD?

Tedicare shows public-source Medicare data for Karen K. Swisher, MD (NPI 1528176955), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karen K. Swisher, MD have ACO affiliation data?

Karen K. Swisher, MD is shown with ACO affiliation data for Aledade A2916 KS MSSP Enhanced (MSSP, ACO ID A2916), Aledade 38 KS CHC MSSP Enhanced (MSSP, ACO ID A4546), Aledade 149 Regional MSSP (MSSP, ACO ID A5231), INTEGRIS Health Partners, LLC (MSSP, ACO ID A5331), Saint Francis Accountable Health Alliance LLC (MSSP, ACO ID A5372), Aledade 201 National MSSP (MSSP, ACO ID A5522), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Karen K. Swisher, MD?

Karen K. Swisher, MD is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Karen K. Swisher, MD have Open Payments data?

Karen K. Swisher, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.